Pharmacopoeia Flashcards

1
Q

Derived from Greek word___meaning drug and
____ meaning to make.

A

pharmakon and poiea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

purpose

A

A legal and official book issued by recognized authorities
appointed by the Government of each country.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

content

A

It comprises a list of pharmaceutical substances, formulae,
descriptions, and standards.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

definition

A

A book containing directions for identifying compound
medicines published by government or medical authorities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list

A

British European Indian

International United States

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BRITISH PHARMACOPOEIA

A

First Edition-Published in 1864.

Content-Two sections: Materia Medica and Preparations &
Compounds.

Early Editions-Published in 1867, 1898,
1914, and 1953.

Eighth Edition-Titles of drugs and
preparations were in
English instead of Latin,
using the metric system.

Current Publication-Published annually.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BRITISH PHARMACOPOEIA
2007-2009 Editions

A

Published in six volumes: I to VI.

Content:
Volumes I & II contain medicinal substances, while Volumes
III-VI cover formulated preparations, blood products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

UNITED STATES
PHARMACOPOEIA

A

First Edition-Published on December 15,
1820, in both Latin and
English.

Early Publication
Frequency-Published at ten-year
intervals from 1820 to
1942.

Later Publication
Frequency-Published at five-year
intervals from 1942 to
2000.

Current Publication-Published annually since
2002.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EUROPEAN
PHARMACOPOEIA

A

Commission Establishment:
The European Pharmacopeia Commission began working in 1964 to prepare the European
Pharmacopeia.

Editions: Editions 1-8 have been published since 1967, each with
a specific publication and validity date.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Monographs must be?

A

Comprehensive

Standardized

Detailed

Substance Specific

EDQM Collaboration

Public Involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The Pharmacopoeia and other
relevant documents on the state of
work must be consulted to see if
______ on similar substances
exist or are being elaborated.

A

monographs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If monographs or draftson similar
substances already exist, it is
important to ensure that the
monograph to be elaborated follows
the ____unless there are
good reasons to deviate

A

same approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Substances that are to be described
in a monograph may be members of
a group of very____

A

similar substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Essential to gather
information on the
substance in question,
including origin,
composition, preparation
methods, and potential
crystalline forms.

A

Information
Gathering (M)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Investigate whether
different enantiomers,
racemates, or mixtures of
enantiomers are available.

A

Enantiomer
Consideration (M)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Determine whether different hydrates or entities (acid, base,
salt) are available.

A

Hydrate and Entity Consideration (M)

17
Q

Consult the Pharmacopoeia
and other relevant
documents to see if
monographs on similar
substances exist or are
being elaborated.

A

Existing Monograph
Consultation (M)

18
Q

Ensure the monograph
follows the same approach
as existing monographs
unless there are compelling
reasons to deviate, e.g.,
developments in analytical
techniques.

A

Consistency and
Deviation (M)

19
Q

Consider substances as part of a family group, especially for
excipients like macrogols.

A

Family groups (M)

20
Q

TITLE

A

INN Use
Use the International
Nonproprietary Name (INN)
established by the World
Health Organization where
available.

Hydration and
Anion/Cation
Indication
Supplement with the name
of the anion or cation,
“hydrate,” “dihydrate,”
“hydrated,” or “anhydrous”
as appropriate.

Veterinary Use
Include “for veterinary use” in the title if the substance is used in
approved medicinal products for veterinary use only in Member
States.

21
Q

DEFINITION

A

Chemical Structure
Ascertain the chemical structure with precision to establish
the exact graphic formula, empirical formula, and relative
molecular mass.

Isomer and Optical Isomer Specification
Specify which isomer is used or state that the product is a
mixture of isomers. For an optical isomer, specify the
absolute configuration.

22
Q

DEFINITION

A

Hydration and Solvation
Distinguish clearly between well-defined hydrates and solvates
and products with variable quantities of solvent(s).

23
Q

COMBINATIONS

A

Chemical Combinations
Specify each component of the combination or mixture, with its
chemical structure and proportion present.

24
Q

CONTENT

A

Impurities
The substance described in
a monograph is never
wholly pure, but contains a
limited proportion of
impurities.

Assay Limits
Assay limits are specified
between which the content
must fall, taking into
account the precision of the
method and acceptable
purity.

Assay Limit Expression
Assay limits are normally expressed with reference to the dried
or anhydrous substance.

25
Q

CONTENT

A

Non-Specific Assay
For a non-specific assay, the assay limits are usually
99.0-101.0% (unless otherwise justified).

Specific Assay
For a specific assay using a separation technique, the
upper assay limit is normally 102.0%, and the lower
assay limit takes into account any impurities present.

26
Q

CHARACTERISTICS

A

Appearance
This description normally
embraces color and physical form.

Solubility
Solvents quoted are normally
confined to water, an alcohol, and
a lipophilic solvent. Solubility in
other solvents may also be
mentioned.